Inhaled Nitric Oxide Market, By Product Type, By Age Group, By Application, By End User, By Geography

Description

Inhaled Nitric Oxide Market is estimated to be valued at USD 1,667.6 Mn in 2026 and is expected to reach USD 3,021.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 1,667.6 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	8.90%	2033 Value Projection:	USD 3,021.4 Mn

Inhaled nitric oxide is an agent that acts selectively as a vasodilator for the lungs, it relaxes the pulmonary vasculature, thus improving the blood flow into areas of good ventilation. This drug is administered mainly in intensive care settings and is commonly used in the management of neonatal hypoxic respiratory failure due to persistent pulmonary hypertension of the newborns. It is also indicated in acute respiratory distress syndrome, pulmonary hypertension, and complications from cardiac and thoracic surgeries. Respiratory diseases have been on the increase, while the dependence on intensive care medicine has also grown in the health care sector.

Inhaled nitric oxide administration systems are experiencing innovations related to their mobility, dose accuracy, and ventilator compatibility. The move towards tank-free and demand-based systems for nitric oxide production can help in making the technology easily accessible while overcoming limitations arising from the handling of nitric oxide gas cylinders. Besides, the development of neonatal and ICU facilities in the developing nations is contributing positively to market dynamics. Yet, high costs involved and the presence of other respiratory management therapies pose restrictions in the market penetration of nitric oxide products. Nevertheless, the potential applications discovered through current clinical studies should be sufficient to ensure future growth in this market.

Market Dynamics

The global inhaled nitric oxide market has witnessed a significant growth due to the growing prevalence of critical respiratory illnesses and the use of intensive care treatment methods. The therapy is widely accepted and recognized as an effective means of oxygenating critical patients who suffer from respiratory distress. The increasing numbers of babies born prematurely and neonatal intensive care units are some of the factors that have been contributing to a consistent increase in the demand for the product. Furthermore, the growing prevalence of respiratory distress syndrome, pulmonary hypertension, and cardiopulmonary disorders is playing an instrumental role in driving the uptake of inhaled nitric oxide.

However, several aspects could hinder the market from experiencing any significant expansion. These include the expensive nature of treatment and equipment, making it difficult for users in healthcare facilities with cost constraints to afford. Besides, there are other techniques available in the industry that act as competition in providing alternatives to assist patients in respiration and other medical conditions. Other challenges include the difficulties in storing and transporting gases, which can be an obstacle in adopting the technology in some health facilities. However, several promising trends exist within the industry, such as the emergence of portable and tankless methods for delivering nitric oxide. This trend will overcome some barriers to adoption within the market, especially those concerning storage and portability.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global inhaled nitric oxide market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Mallinckrodt Pharmaceuticals, Linde plc, Air Liquide, VERO Biotech, Beyond Air, Bellerophon Therapeutics, Getinge AB, Nu-Med Plus, International Biomedical, and Messer Group
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global inhaled nitric oxide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global inhaled nitric oxide market

Market Segmentation

Product Type Insights (Revenue, USD Mn, 2021 - 2033)
Inhaled Nitric Oxide Delivery Systems
Consumables
Age Group Insights (Revenue, USD Mn, 2021 - 2033)
Neonates
Pediatrics
Adults
Application Insights (Revenue, USD Mn, 2021 - 2033)
Neonatal Respiratory Treatment (Persistent Pulmonary Hypertension of the Newborn)
Acute Respiratory Distress Syndrome (ARDS)
Pulmonary Hypertension
Surgery and Postoperative Management
Others
End User Insights (Revenue, USD Mn, 2021 - 2033)
Hospitals
Ambulatory Surgical Centers
Home Care Settings
Others
Regional Insights (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Mallinckrodt Pharmaceuticals
Linde plc
Air Liquide
VERO Biotech
Beyond Air
Bellerophon Therapeutics
Getinge AB
Nu-Med Plus
International Biomedical
Messer Group

Product Code: CMI7478

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Inhaled Nitric Oxide Market, By Product Type
- Global Inhaled Nitric Oxide Market, By Age Group
- Global Inhaled Nitric Oxide Market, By Application
- Global Inhaled Nitric Oxide Market, By End User
- Global Inhaled Nitric Oxide Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Regulatory Scenario
Key Developments
Industry Trends

4. Global Inhaled Nitric Oxide Market, By Product Type, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Inhaled Nitric Oxide Delivery Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Inhaled Nitric Oxide Market, By Age Group, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Neonates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Pediatrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Inhaled Nitric Oxide Market, By Application, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Neonatal Respiratory Treatment (Persistent Pulmonary Hypertension of the Newborn)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Acute Respiratory Distress Syndrome (ARDS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Pulmonary Hypertension
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Surgery and Postoperative Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Inhaled Nitric Oxide Market, By End User, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

8. Global Inhaled Nitric Oxide Market, By Region, 2021 - 2033, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Mallinckrodt Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Linde plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Air Liquide
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
VERO Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Beyond Air
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bellerophon Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Getinge AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Nu-Med Plus
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
International Biomedical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Messer Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

10. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us